ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,681 | -32.4% | 3,253 | -13.3% | 0.00% | – |
| Q2 2023 | $29,131 | +164.8% | 3,754 | +48.4% | 0.00% | – |
| Q2 2022 | $11,000 | -78.4% | 2,530 | -73.7% | 0.00% | – |
| Q1 2022 | $51,000 | -64.1% | 9,606 | 0.0% | 0.00% | – |
| Q4 2021 | $142,000 | -24.9% | 9,606 | +6.2% | 0.00% | – |
| Q3 2021 | $189,000 | +155.4% | 9,046 | +117.6% | 0.00% | – |
| Q2 2021 | $74,000 | -32.7% | 4,157 | -7.7% | 0.00% | – |
| Q1 2021 | $110,000 | 0.0% | 4,502 | +38.9% | 0.00% | – |
| Q4 2020 | $110,000 | +307.4% | 3,242 | +202.4% | 0.00% | – |
| Q3 2020 | $27,000 | -42.6% | 1,072 | -24.1% | 0.00% | – |
| Q2 2020 | $47,000 | – | 1,412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |